What is the leaky gut? Clinical considerations in humans

被引:29
作者
Camilleri, Michael [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Clin Enter Neurosci Translat & Epidemiol Res CENT, Rochester, MN USA
基金
美国国家卫生研究院;
关键词
barrier; diet; leak; mucus; permeability; pore; tight junctions; INCREASED INTESTINAL PERMEABILITY; BOWEL SYNDROME-DIARRHEA; CROHNS-DISEASE; BARRIER; RELATIVES;
D O I
10.1097/MCO.0000000000000778
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review To review the components of the intestinal barrier, the practical measurements of intestinal permeability, and the clinical conditions associated with altered intestinal barrier function, and to summarize the effects of dietary substances that fortify or weaken the intestinal barrier. Recent findings The intestinal barrier includes surface mucus, epithelial layer, and immune defense mechanisms. Transport across the epithelium may result from increased paracellular transport, apoptosis, or transcellular permeability. Assessment of the intestinal barrier requires measurements beyond the transport across the epithelial layer or the measurement of tight junction expression. Barrier function is most meaningfully tested in vivo using orally administered probe molecules; other approaches are performed in vitro using mucosal biopsies from humans, or exposing colonic mucosa from rats or mice or cell layers to extracts of colonic mucosa or stool from patients. Dietary factors can influence intestinal leakiness: fortifying the barrier with vitamins A and D, zinc, short-chain fatty acids, methionine, glutamine, and probiotics; weakening of the barrier has been reported with fat, bile acids, emulsifiers, and gliadin. Intestinal mucosal leakiness in 'stress' disorders such as major burns is reversed with enteral glutamine. Inflammatory or ulcerating intestinal diseases result in leakiness of the gut barrier; however, no such disease has been cured by simply normalizing intestinal barrier function. Similarly, it is still unproven that restoring barrier function (reversing 'leaky gut') can ameliorate clinical manifestations in nonulcerating gastrointestinal disease or systemic or neurological diseases. On the other hand, dietary and enteral interventions can fortify the intestinal barrier in stress-associated states.
引用
收藏
页码:473 / 482
页数:10
相关论文
共 37 条
[1]   Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD) [J].
Aguas, Mariam ;
Garrigues, Vicente ;
Bastida, Guillermo ;
Nos, Pilar ;
Ortiz, Vicente ;
Fernandez, Alberto ;
Ponce, Julio .
JOURNAL OF CROHNS & COLITIS, 2011, 5 (03) :227-233
[2]   Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial [J].
Alberda, Cathy ;
Gramlich, Leah ;
Meddings, Jon ;
Field, Catherine ;
McCargar, Linda ;
Kutsogiannis, Demetrios ;
Fedorak, Richard ;
Madsen, Karen .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 85 (03) :816-823
[3]   Bifidobacteria Stabilize Claudins at Tight Junctions and Prevent Intestinal Barrier Dysfunction in Mouse Necrotizing Enterocolitis [J].
Bergmann, Kelly R. ;
Liu, Shirley X. L. ;
Tian, Runlan ;
Kushnir, Anna ;
Turner, Jerrold R. ;
Li, Hong-Lin ;
Chou, Pauline M. ;
Weber, Christopher R. ;
De Plaen, Isabelle G. .
AMERICAN JOURNAL OF PATHOLOGY, 2013, 182 (05) :1595-1606
[4]   Intestinal permeability - a new target for disease prevention and therapy [J].
Bischoff, Stephan C. ;
Barbara, Giovanni ;
Buurman, Wim ;
Ockhuizen, Theo ;
Schulzke, Joerg-Dieter ;
Serino, Matteo ;
Tilg, Herbert ;
Watson, Alastair ;
Wells, Jerry M. .
BMC GASTROENTEROLOGY, 2014, 14
[5]   Genetic basis for increased intestinal permeability in families with Crohn's disease:: role of CARD15 3020insC mutation? [J].
Buhner, S ;
Buning, C ;
Genschel, J ;
Kling, K ;
Herrmann, D ;
Dignass, A ;
Kuechler, I ;
Krueger, S ;
Schmidt, HHJ ;
Lochs, H .
GUT, 2006, 55 (03) :342-347
[6]  
Camilleri M., 2021, CLIN TRANSLATIONAL G, V12
[7]   Leaky gut: mechanisms, measurement and clinical implications in humans [J].
Camilleri, Michael .
GUT, 2019, 68 (08) :1516-1526
[8]   Intestinal permeability test as a predictor of clinical course in Crohn's disease [J].
D'Incà, R ;
Di Leo, V ;
Corrao, G ;
Martines, D ;
D'Odorico, A ;
Mestriner, C ;
Venturi, C ;
Longo, G ;
Sturniolo, GC .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (10) :2956-2960
[9]   Improving the detection of environmental enteric dysfunction: a lactulose, rhamnose assay of intestinal permeability in children aged under 5 years exposed to poor sanitation and hygiene [J].
Faubion, W. A. ;
Camilleri, M. ;
Murray, J. A. ;
Kelly, P. ;
Amadi, B. ;
Kosek, M. N. ;
Enders, F. ;
Larson, J. ;
Grover, Madhusudan ;
Boe, G. ;
Dyer, R. ;
Singh, R. .
BMJ GLOBAL HEALTH, 2016, 1 (01)
[10]   Gut microbiota as a source of novel antimicrobials [J].
Garcia-Gutierrez, Enriqueta ;
Mayer, Melinda J. ;
Cotter, Paul D. ;
Narbad, Arjan .
GUT MICROBES, 2019, 10 (01) :1-21